Elscint's major investment in MRI has apparently begun to payoff. The Haifa, Israel, company this month reported that a 120%increase in MRI sales contributed to strong revenue growth in1996, although the vendor is experiencing profitability problemsthat
Elscint's major investment in MRI has apparently begun to payoff. The Haifa, Israel, company this month reported that a 120%increase in MRI sales contributed to strong revenue growth in1996, although the vendor is experiencing profitability problemsthat have required some cost-reduction measures.
For the year (end-December), Elscint reported revenues of $311.4million, up 10% compared with $281.9 million in 1995. The companyhad net income last year of $8.1 million, compared with $14.5million the year before.
In the past several years, Elscint has broadened its once-thinMRI product line and now offers scanners at five different fieldstrengths. Its most recent new magnet introduction was the 1-teslaPrima 1TG, which debuted at last year's Radiological Society ofNorth America meeting (SCAN 12/4/96).
In addition to its growth in MRI revenues, Elscint said that systemssales in the U.S. increased 25%, mostly due to the success ofits CT Twin Flash scanner, which gained market share in the modality.Fourth-quarter sales in Elscint's nuclear medicine division alsogrew, due to shipments of its VariCam variable-angle, dual-headcamera.
Despite the revenue growth, Elscint president and CEO JonathanAdereth said that the company was disappointed with its levelsof profitability. To cut costs, Elscint has reduced personnel,reorganized some of its regional operations, and instituted asalary freeze. Along with an effort to reduce manufacturing costs,the moves should improve operating profit through 1997, Aderethsaid.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.